Mizuho cuts Harmony Biosciences target price to $49 from $51
HRMY•Mizuho cut its target price for Harmony Biosciences to $49 from $51.
Related News
Stifel raises Microsoft target price to $650 from $575
MSFT•
Crane Company target price raised to $247 from $242
CR•
Upbound Group Q3 revenue beats on Acima, Brigit growth
UPBD•
Tradeweb Q3 revenue slightly beats on robust wholesale activity
TW•
Americold names Anita Nanda chief technology & solutions officer
COLD•